Comprehensive Panomic Profiling Service
Cancer (broad)
CommercialActive
Key Facts
About NantOmics
NantOmics is a private, US-based leader in molecular diagnostic testing for oncology, founded in 2012 by Dr. Patrick Soon-Shiong. The company's core offering is a comprehensive, integrated panomic analysis service that sequences DNA and RNA and measures protein levels from a patient's tumor to identify actionable alterations and match them to targeted therapies. As part of the NantWorks ecosystem, it aims to transform cancer care by enabling precision medicine through deep molecular profiling and data-driven clinical decision support.
View full company profileTherapeutic Areas
Other Cancer (broad) Drugs
| Drug | Company | Phase |
|---|---|---|
| iPSC-based Cancer Vaccine | Khloris Biosciences | Pre-clinical |
| CD24 Platform | OncoC4 | Not Disclosed |